Anti-angina
drug shows protective effects from carbon monoxide
An
international research team, led from the University of Leeds, has found that a
common anti-angina drug could help protect the heart against carbon monoxide
poisoning.
Animal
studies have shown that the anti-angina drug ranolazine can significantly
reduce the number of deaths from arrhythmias – irregular or abnormally paced
heartbeats – that have been triggered by carbon monoxide.
to read
more, click here